Home › IGA Glomerulonephritis › Texas › Houston
IGA Glomerulonephritis clinical trials in Houston, TX
9 studies for IGA Glomerulonephritis are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
RecruitingPhase 2
- Jade Clinical Site, Houston
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
RecruitingPhase 3
- Provecta Research Network, Houston
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
RecruitingPhase 2
- ADARx Clinical Site, Houston
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RecruitingPhase 3
- Nephro Asso North Illinois Indiana, Houston
Study of WAL0921 in Patients With Glomerular Kidney Diseases
RecruitingPhase 2
- Prolato Clinical Research Center, Houston
- Clinical Trial Network, Houston
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
RecruitingPhase 2
- Prolato Clinical Research Center, Houston
Study of BHV-1400 in IgA Nephropathy
RecruitingPhase 1
- Site-014, Houston
- Site-004, Houston
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RecruitingPhase 2
- Texas Children's Hospital, Houston
Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
RecruitingPhase 2
- Clinical Research Site 324, Houston
IGA Glomerulonephritis trials in other cities
- Denver, CO5 studies
- Orlando, FL5 studies
- Los Angeles, CA4 studies
- Sioux City, IA4 studies
- Cedar Rapids, IA3 studies
- New York City, NY3 studies
- Boston, MA3 studies
- Philadelphia, PA3 studies
- Johns Creek, GA3 studies
- Columbus, OH3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)123 studies
- Metastatic Cancer104 studies
- Colorectal Cancer101 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.